1. Evaluation of the mutagenicity of the anti-inflammatory drug salicylazosulfapyridine (SASP)
2. Canada (1989): Genotoxicity Assays Recommended in the Health Protection Branch Genotoxicity Committee Report. Conduct and Reporting for Effective Evaluation. Department of National Health and Welfare, Health Protection Branch, Ottawa, Canada. pp 23–28. As amended by D.H. Blakey, personal communication, 1991.
3. CSGMT (1991): Collaborative Study Group for the Micronucleus Test. Micronucleus test with mouse peripheral blood erythrocytes by acridine orange supravital staining: The summary report of the 5th collaborative study by CSGMT/JEMS.MMs, Mutat Res (submitted).
4. EEC (1989): EEC Directive 79/831, Annex V, Part B: Methods for the Determination of Toxicity. B12. Mutagenicity (Micronucleus Test). Updated Guidelines. Draft Minutes of the 27th Meeting of National Experts, pp 25–33.